Spirometry Market Research Report – Forecast to 2027

Spirometry Market Research Report, by Product (Table-top Spirometry, Hand-held Spirometry, Desktop Spirometry), Technology (PFM, Volume Measurement Spirometry, Flow Measurement Spirometry), Application (Diagnostic, Treatment Monitoring), End-user (Hospitals & Clinics, Home Care, Diagnostic Centers, Research & Academic Institutes), and Region - Forecast to 2027

ID: MRFR/MED/5077-CR | October 2018 | Region: Global | 120 pages

Spirometry Market overview


The CAGR for the spirometry market is projected to be 10.3% until 2023. Its value is projected to be USD 1,106.7 million by then. Spirometry is invaluable because it helps doctors determine the real health of a person’s lungs. Thus, it is a good lung cancer screening aide. It’s also great in determining if a person has asthma or other serious respiratory/breathing problems. 


There is more of a prevalence in breathing and/or respiratory problems in global societies. This is especially true in developed nations because their populations are aging rapidly and a high number of the elderly in these nations used to smoke cigarettes when they were younger. 


COVID-19 analysis


COVID-19 is to the 21st century what the Black Death were to the 5th and 14th centuries - a real destiny changer for the world. COVID-19 can be a dangerous virus. Governments realized this early on and that’s why they implemented quarantines and lockdowns. These were temporary in nature since they were not very effective. In any case, many companies in many industries were negatively affected since they were forced to either temporarily halt production or dramatically scale back operations. 


Well, the spirometry market actually benefited from COVID-19. There were many reasons for this but the main one was that COVID-19 caused breathing problems in many people. Doctors had to use complicated spirometry devices to correctly diagnose these problems. 


Market dynamics


Drivers


The spirometry market has been growing dramatically mainly because there is a dramatic increase in the number of people with serious breathing problems around the world. In fact, respiratory and other breathing problems are the fifth largest killer of people around the world every year. 


COPD is the third largest killer of people around the world every year. These and other respiratory problems tend to be diagnosed heavily with spirometry equipment because they can be treated and even reversed if caught early. 


Opportunities


There are many opportunities for companies in the spirometry market. Most of the world’s population lives in developing countries like Brazil, India, and China. The cities in these nations tend to be extremely polluted. For example, India alone has 14 out of the world’s top 20 cities in terms of pollution. Added to this is the fact that growing numbers of people in developing nations are starting to smoke. They are doing so because they think that smoking is ‘cool!’ 


Restraints


People can be correctly diagnosed with a spirometry device only if they exhale at full blast into it for at least 6 seconds. Furthermore, they will have to do this at least three times in a row. This is the only way doctors can ensure that the test results are 100% accurate. Many people with chronic breathing and respiratory problems may have a hard time doing so. This factor is what is restraining growth in the spirometry market. 


Challenges


Other devices that detect breathing problems in people and test their overall breathing abilities are just as effective as spirometry devices. In fact, some of these may even be less expensive. This is a key challenge that the spirometry market faces. 


Cumulative growth analysis.


The CAGR for the spirometry market is projected to be 10.03% in 2023. The market is expected to be worth USD 1,106.76 million by then. 


Technology analysis


Midmark is a major American player in the spirometry market. It has managed to become an industry leader by investing heavily in research and development. This has allowed it to develop a new generation of more effective spirometers that have also allowed it to justify selling them at a higher price point (when marketed correctly!) 


Segment overview


By product


The spirometry market can be grouped into the following sub-categories by-product:



  • Hand-held spirometry

  • Desk-top spirometry

  • Tabletop spirometry 


By technology


The spirometry market can be grouped into the following subcategories by the technology used:



  • Volume

  • Flow measurement

  • Peak flow meters 


The flow measurement sub-segment had the largest spirometry market size in this segment two years ago. This sub-segment is also projected to have the highest CAGR of all of the sub-segments (in this segment) until 2023. There are two reasons for this. The first is that spirometers are becoming more and more sophisticated and sensitive in terms of detecting acute breathing and respiratory issues. The second is that there is rapid growth in the number of people who need to use these devices. 


By end user


The spirometry market can be grouped into the following sub-categories based on end user:



  • Research and academic institutions

  • Home care organizations

  • Clinics

  • Diagnostics centers

  • Hospitals 


The hospital sub-segment had the highest spirometry market share in 2019. The reason is that the population is aging rapidly and this segment is growing the fastest. The second reason is that hospitals receive big reimbursements for using these devices, especially in developed nations. The third is because hospitals are using more advanced and sophisticated spirometry devices. 


By application


The spirometry market can be grouped into the following subcategories based on application:



  • Diagnosis

  • Treatment monitoring 


The diagnosis sub-segment can be further divided into asthma, COPD, and interstitial pulmonary fibrosis, etc. The COPD sub-segment had the greatest spirometry market share as of two years ago. There were a few reasons for this. One was that COPD is easy to diagnose early on and there are more and more people who are developing COPD globally (again, this is attributed to a rapidly aging population!) 


Regional analysis


The spirometry market can be divided into the following regions:



  • North America

  • The European Union

  • Asia-Pacific

  • The rest of the world 


The North American region is expected to have the greatest spirometry market share during the period covered in this report because it has the greatest number of companies that are investing heavily in research and development. They are able to develop and launch a greater number of sophisticated spirometers that have more diverse and innovative uses. 


The geriatric population in America is exploding as the baby boomers are aging. Many of these people smoked when they were younger. This is also fueling the rapid growth rate in the spirometry market in this region. Also, most hospitals in America are handsomely reimbursed for using these devices. 


That said, the nations in the Asia-Pacific region and the European Union may be seeing the greatest regional growth. There are many reasons for this. One is because they are investing heavily in developing better spirometers. They are also working hard to ensure that more and more medical care settings (in their nations) have access to these spirometers and know how to use them! 


The rest of the world is seeing at least respectable growth in this market because the nations there are developing the infrastructure needed to support the greater usage of these devices. They need to do this because the number of people with lung and breathing problems is growing rapidly. Part of this is because of increased pollution. However, the rise of people smoking is also a key contributor. 


Competitive landscape


The spirometry market is very competitive. What accounts for this is the fact that there is a lot of money to be made (in this market) and there are few barriers to entry. Many companies (especially larger ones) around the world are noticing this and that’s why they’re entering the market at breakneck speed. 


Companies are finding that they have to invest heavily in research and development to come up with newer and more innovative spirometers with more useful applications if they want to continue to develop a sustainable competitive advantage that will keep them profitable. 


These companies are also finding that partnering with other successful companies can give them the edge that they need by increasing their overall resources. This is invaluable if they do research and development and continue to develop and market better products. They can also strengthen their positions in existing markets and enter new markets with ease. 


Incidentally, companies find themselves in the same position when they merge with/acquire other successful companies. 


Midmark Corporation is a successful American company. It became an industry leader by creating a sustainable competitive advantage. Extensive investments in research and development allowed it to do this! 


List of companies



  • NDD Medical Technologies, Inc. (U.S.)

  • Carefusion Corporation (U.S.)

  • MGC Diagnostics Corporation (U.S.)

  • Hill-Rom Holdings, Inc. (U.S.)

  • Nihon Kohden Corporation (Germany)

  • Midmark Corporation (U.S.)

  • Schiller AG (Switzerland)

  • Koninklijke Philips N.V. (The Netherlands)

  • Smiths Medical Inc. (U.S.)

  • MGC Diagnostics Corporation (U.S.)

  • Vitalograph (U.K.)

  • COSMED SRL (Italy)


Recent developments



  • AG Shiller recently opened a new manufacturing site in China

  • AG Schiller launched a new spirometer using brand new and innovative technologies - the CARDIOVIT CS-200 ErgoSpiro system device

  • MIR partnered with a Canadian company to find better tools for diagnosing COPD 


Report overview


The CAGR for the spirometry market is projected to be 10.03%  until 2023. The market will be worth USD 1,106.76 million by then. The North American market has the highest market share but the European Union, the Asia-Pacific region, and the rest of the world have the highest CAGR.



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 1,106.76 Million
  • 2027: Significant Value
  •   CAGR   10.03% (2019-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product offered, Technology, Application, End-user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   NDD Medical Technologies Inc. (U.S.), Carefusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), Hill-Rom Holdings Inc. (U.S.), Nihon Kohden Corporation (Germany), Midmark Corporation (U.S.), Schiller AG (Switzerland), Koninklijke Philips N.V. (The Netherlands), Smiths Medical Inc. (U.S.), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), COSMED srl (Italy)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers   The respiratory issues and high spread of diseases


    Speak to Analyst Ask for Customization

    Spirometry Market – Summary


    Advancing technologies have triggered torrid actions across the healthcare sector. Latest machineries are providing extraordinary service right from the scratch to the most sophisticated ones. Spirometry is one such test that has considerable impact in determining lung conditions. It monitors and comprehends an individual’s oxygen intake capacity in one forced breath which can play a pivotal role in diagnosing asthma, chronic obstructive pulmonary disease (COPD), and different conditions that affect breathing patterns. The spirometry market can rise to USD 1,106.46 million by 2023, almost double of the present valuation, at USD 623.66 million (2017). A CAGR of 10.03% can be expected during the forecast period (2018-2023). Market research Future’s report on the same has an extensive look into the drivers and segments that can help in a better assessment of the market in coming years.


    Growing geriatric population and an increasing number of smokers are causing asthma and COPD which can create a business opportunity for the spirometry market. Furthermore, people getting killed from COPD has risen in recent years, and its 4 million death count can be considered daunting. This can allow the spirometry market a broader spectrum of operation.


    On the other hand, technological advancement is helping in the mechanism of spirometry and companies are investing much in launching products which would help them in staying ahead of the rest. Wider range of equipment often helps in attaining a broader customer base.


    However, reimbursement limitations can prove detrimental to the market. In the U.S. reimbursement policy only allow a partial one which can affect the regular growth of the spirometer market. At the same time, spirometers incur heavy cost and tests require different spirometers as per their effectiveness. This can slacken the growth rate of the spirometer market by a considerable margin.


    Industry Opportunity:


    Combination therapies are getting much precedence in spirometry tests. At the same time, developing countries are ushering in new technologies in healthcare creating further scope for the spirometry test market. Combination therapies are proving more effective than the traditional ones. Increase in the application of such treatments can be seen as beneficial for the spirometry market.


    Segmentation:


    By product, the spirometry market can be segmented into table-top, hand-held, and desktop. Table-top spirometry is accounted for the largest market share. In 2017, its market valuation was USD 311.24 Bn which can now see a good rise to USD 539.4 million during the forecast period at a CAGR of 9.60%. However, desktop spirometry is expected to score the best CAGR. Its growth is predicted to set for CAGR 10.58%.


    By technology, the spirometry market can be segmented into flow measurement, volume measurement, and peak flow. Flow measurement is going to enjoy its present superior status for the time being and is expected to do so during the forecast period. From USD 313.60% the market can climb to USD 545.86 million at a 9.67% market share during the forecast period. Meanwhile, peak flow meter is expected to register the fastest CAGR of 10.58%, better than its peers.


    By application, the spirometry market can be segmented into diagnostic and treatment monitoring, Diagnostic can be expected to fetch the maximum market valuation of USD 753.6 million at a CAGR of 9.81% during the forecast period. However, treatment monitoring can expect the fastest CAGR of 10.5% during the forecast period.


    Based on end-users, the spirometry market can be segmented into hospitals & clinics, research & academic institutes, diagnostic centers, and homecare. Hospitals & clinics are expected to retain their top position with an anticipated market valuation of USD 409.23 million and 9.52% CAGR during the forecast period. However, its research & academic institutes that are predicted to grow with the fastest rate. IT is touted to catch a 10.35% CAGR during the forecast period.


    Regional Analysis:


    Region-specific analysis of the spirometry market covers the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).


    The market of the Americas is presently valued at USD 273.19 million which can go up to USD 444.99 million by 2023 with an impressive CAGR of 10.25% during the forecast period. State-of-the-art facilities and superior infrastructure, coupled with growing awareness can help the regional spirometry market grow at such a rate.


    Europe is following the lead closely and is expected to climb up to USD 322.33 million market valuation with the same CAGR as that of the Americas during the forecast period. However, it’s the APAC market that is expected to beat all in terms of CAGR. Its projected CAGR can touch 10.64% value during the forecast period, and the market valuation can easily reach USD 247.52 million mark.


    Market Insight:


    Prominent players influencing the spirometry market are COSMED Srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), MGC Diagnostics Corporation (U.S.), Nihon Kohden Corporation (Germany), NDD Medical Technologies, Inc. (U.S.), Schiller AG (Switzerland), CareFusion Corporation (U.S.), Midmark Corporation (U.S.), Vitalograph (U.K.), Smiths Medical Inc. (U.S.), and others. Acquisitions, a much-tested strategy is dominating the market. Almost 66.7% of the market depends on this. Vyaire Medical, acquiring Acutronic Medical Systems can be considered exemplary. They have also taken over Revolutionary Medical Devices in October 2017.

    1 Report Prologue

    2 Market Introduction

    2.1 Scope of Study 19

    2.2 Research Objective 19

    2.3 List of Assumptions 19

    2.4 Market Structure 20

    3 Research Methodology

    3.1 Research Process 22

    3.2 Primary Research 23

    3.3 Secondary Research 24

    3.4 Market Size Estimation 25

    3.5 Forecast Model 25

    4 Market Dynamics

    4.1 Introduction 27

    4.2 Drivers 27

    4.2.1 Increasing prevalence of asthma and COPD 27

    4.2.2 Rise in the number of smokers 27

    4.2.3 Technological advancements in the field of respiratory care devices 28

    4.3 Restraints 28

    4.3.1 Limited reimbursement scenario 28

    4.3.2 High cost of spirometers 30

    4.3.3 No single, effective diagnostic device for every respiratory disorder 30

    4.4 Opportunities 31

    4.4.1 Increasing use of combination therapy 31

    4.4.2 Increasing demand in developing countries 31

    4.5 Macroeconomic indicators 32

    4.6 Technological Trends 33

    4.6.1 The recent technological advancements have increased the appeal of spirometry 33

    5 Market Factor Analysis

    5.1 Porter’s Five Forces Model 35

    5.1.1 Bargaining Power of Suppliers 35

    5.1.2 Bargaining Power of Buyers 35

    5.1.3 Threat of New Entrants 35

    5.1.4 Threat of Substitutes 36

    5.1.5 Intensity of Rivalry 36

    5.2 Supply Chain Analysis 36

    5.2.1 R&D 36

    5.2.2 Manufacturing 37

    5.2.3 Distribution & Sales 37

    5.2.4 Post-Sales Monitoring 37

    5.3 Pricing Analysis 37

    5.4 Demand & Supply: Gap Analysis 38

    5.5 Regulatory Framework 38

    6 Spirometry Market, By Product

    6.1 Introduction 40

    6.1.1 Table-Top Spirometry 41

    6.1.2 Hand-Held Spirometry 41

    6.1.3 Desktop (PC) Spirometry 41

    7 Spirometry Market, By Technology

    7.1 Introduction 43

    7.1.1 Flow Measurement Spirometry 44

    7.1.1.1 Pneumotachograph System 44

    7.1.1.2 Mass Flow Meter 44

    7.1.2 Volume Measurement Spirometry 45

    7.1.3 Peak Flow Meter (PFM) 45

    8 Spirometry Market, By Application

    8.1 Introduction 47

    8.1.1 Diagnostic 48

    8.1.1.1 COPD 49

    8.1.1.2 Interstitial Pulmonary Fibrosis 49

    8.1.1.3 Asthma 49

    8.1.2 Treatment Monitoring 50

    9 Spirometry Market, By End User

    9.1 Introduction 52

    9.1.1 Hospitals & Clinics 53

    9.1.2 Research & Academic Institutes 53

    9.1.3 Diagnostic Centres 54

    9.1.4 Home Care 54

    10 Global Spirometry Market, By Region

    10.1 Introduction 56

    10.2 Americas 57

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.2.1 North America 60

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.2.1.1 US 62

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.2.1.2 Canada 64

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.2.2 South America 66

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.3 Europe 68

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4 Western Europe 71

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.1 Germany 73

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.2 UK 75

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.3 France 77

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.4 Spain 79

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.5 Italy 81

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.6 Rest of Western Europe 83

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.4.7 Eastern Europe 85

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5 Asia-Pacific 87

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.1 China 90

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.2 Japan 92

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.3 India 94

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.4 Australia 96

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.5 South Korea 98

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.5.6 Rest of Asia-Pacific 100

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.6 Middle East & Africa 102

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.6.1 Middle East 104

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    10.6.2 Africa 106

    Spirometry Market, By Product

    Spirometry Market, By Technology

    Spirometry Market, By Application

    Spirometry Market, By End User

    11 Competitive Landscape

    11.1 Competitive Scenario 109

    11.1.1 Introduction 109

    11.2 Company Market Share Analysis 110

    11.2.1 Introduction 110

    11.3 Key Developments 111


    12 Company Profiles

    12.1 COSMED srl 113

    12.1.1 Company Overview 113

    12.1.2 Financial Overview 113

    12.1.3 Products Offering 113

    12.1.4 Key Developments 113

    12.1.5 SWOT Analysis 113

    12.1.6 Key Strategy 114

    12.2 Hill-Rom Holdings, Inc. 115

    12.2.1 Company Overview 115

    12.2.2 Financial Overview 115

    12.2.3 Products Offering 116

    12.2.4 Key Developments 116

    12.2.5 SWOT Analysis 116

    12.2.6 Key Strategy 116

    12.3 Koninklijke Philips N.V. 117

    12.3.1 Company Overview 117

    12.3.2 Financial Overview 117

    12.3.3 Products Offering 118

    12.3.4 Key Developments 118

    12.3.5 SWOT Analysis 118

    12.3.6 Key Strategy 118

    12.4 MGC Diagnostics Corporation 119

    12.4.1 Company Overview 119

    12.4.2 Financial Overview 119

    12.4.3 Products Offering 119

    12.4.4 Key Developments 119

    12.4.5 SWOT Analysis 119

    12.4.6 Key Strategy 120

    12.5 Nihon Kohden Corporation 121

    12.5.1 Company Overview 121

    12.5.2 Financial Overview 121

    12.5.3 Products Offering 122

    12.5.4 Key Developments 122

    12.5.5 SWOT Analysis 122

    12.5.6 Key Strategy 122

    12.6 NDD Medical Technologies, Inc. 123

    12.6.1 Company Overview 123

    12.6.2 Financial Overview 123

    12.6.3 Products Offering 123

    12.6.4 Key Developments 123

    12.6.5 SWOT Analysis 123

    12.6.6 Key Strategy 124

    12.7 Schiller AG 125

    12.7.1 Company Overview 125

    12.7.2 Financial Overview 125

    12.7.3 Products Offering 125

    12.7.4 Key Developments 125

    12.7.5 SWOT Analysis 125

    12.7.6 Key Strategy 126

    12.8 Carefusion Corporation 127

    12.8.1 Company Overview 127

    12.8.2 Financial Overview 127

    12.8.3 Products Offering 128

    12.8.4 Key Developments 128

    12.8.5 SWOT Analysis 129

    12.8.6 Key Strategy 129

    12.9 Midmark Corporation 130

    12.9.1 Company Overview 130

    12.9.2 Financial Overview 130

    12.9.3 Products Offering 130

    12.9.4 Key Developments 130

    12.9.5 SWOT Analysis 130

    12.9.6 Key Strategy 130

    12.10 Vitalograph 131

    12.10.1 Company Overview 131

    12.10.2 Financial Overview 131

    12.10.3 Products Offering 131

    12.10.4 Key Developments 131

    12.10.5 SWOT Analysis 131

    12.10.6 Key Strategy 132

    12.11 Smiths Medical Inc. 133

    12.11.1 Company Overview 133

    12.11.2 Financial Overview 133

    12.11.3 Products Offering 134

    12.11.4 Key Developments 134

    12.11.5 SWOT Analysis 134

    12.11.6 Key Strategy 134

    13 Appendix

    13.1 Discussion Blue Print 136

    14 List of Tables

    TABLE 1 MARKET SYNOPSIS 17

    TABLE 2 LIST OF ASSUMPTIONS 19

    TABLE 3 CPT CODE TEST DESCRIPTION (JANUARY 2020) 28

    TABLE 4 ICD-9 CODES FOR SPIROMETRY 29

    TABLE 5 GLOBAL SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 40

    TABLE 6 GLOBAL SPIROMETRY MARKET FOR TABLE-TOP SPIROMETRY, BY REGION 2020-2027 (USD MILLION) 41

    TABLE 7 GLOBAL SPIROMETRY MARKET FOR HAND-HELD SPIROMETRY, BY REGION 2020-2027 (USD MILLION) 41

    TABLE 8 GLOBAL SPIROMETRY MARKET FOR DESKTOP (PC) SPIROMETRY, BY REGION 2020-2027 (USD MILLION) 41

    TABLE 9 GLOBAL SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 43

    TABLE 10 GLOBAL SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY REGION 2020-2027 (USD MILLION) 44

    TABLE 11 GLOBAL SPIROMETRY MARKET FOR PNEUMOTACHOGRAPH SYSTEM, BY REGION 2020-2027 (USD MILLION) 44

    TABLE 12 GLOBAL SPIROMETRY MARKET FOR MASS FLOW METER, BY REGION 2020-2027 (USD MILLION) 44

    TABLE 13 GLOBAL SPIROMETRY MARKET FOR VOLUME MEASUREMENT SPIROMETRY, BY REGION 2020-2027 (USD MILLION) 45

    TABLE 14 GLOBAL SPIROMETRY MARKET FOR PEAK FLOW METER (PFM), BY REGION 2020-2027 (USD MILLION) 45

    TABLE 15 GLOBAL SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 47

    TABLE 16 GLOBAL SPIROMETRY MARKET, FOR DIAGNOSTIC BY TYPE, 2020-2027 (USD MILLION) 48

    TABLE 17 GLOBAL SPIROMETRY MARKET, FOR DIAGNOSTIC BY REGION, 2020-2027 (USD MILLION) 48

    TABLE 18 GLOBAL SPIROMETRY MARKET, FOR COPD BY REGION, 2020-2027 (USD MILLION) 49

    TABLE 19 GLOBAL SPIROMETRY MARKET, FOR INTERSTITIAL PULMONARY FIBROSIS BY REGION, 2020-2027 (USD MILLION) 49

    TABLE 20 GLOBAL SPIROMETRY MARKET, FOR ASTHMA BY REGION, 2020-2027 (USD MILLION) 49

    TABLE 21 GLOBAL SPIROMETRY MARKET, FOR TREATMENT MONITORING BY REGION, 2020-2027 (USD MILLION) 50

    TABLE 22 GLOBAL SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 52

    TABLE 23 GLOBAL SPIROMETRY MARKET FOR HOSPITALS & CLINICS, BY REGION 2020-2027 (USD MILLION) 53

    TABLE 24 GLOBAL SPIROMETRY MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION 2020-2027 (USD MILLION) 53

    TABLE 25 GLOBAL SPIROMETRY MARKET FOR DIAGNOSTIC CENTERS, BY REGION 2020-2027 (USD MILLION) 54

    TABLE 26 GLOBAL SPIROMETRY MARKET FOR HOME CARE, BY REGION 2020-2027 (USD MILLION) 54

    TABLE 27 GLOBAL SPIROMETRY MARKET, BY REGION 2020-2027 (USD MILLION) 56

    TABLE 28 AMERICAS SPIROMETRY MARKET, BY REGION 2020-2027 (USD MILLION) 57

    TABLE 29 AMERICAS SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 58

    TABLE 30 AMERICAS SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 58

    TABLE 31 AMERICAS SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 59

    TABLE 32 AMERICAS SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 59

    TABLE 33 AMERICAS SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 59

    TABLE 34 AMERICAS SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 59

    TABLE 35 NORTH AMERICA SPIROMETRY MARKET, BY COUNTRY 2020-2027 (USD MILLION) 60

    TABLE 36 NORTH AMERICA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 60

    TABLE 37 NORTH AMERICA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 61

    TABLE 38 NORTH AMERICA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 61

    TABLE 39 NORTH AMERICA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 61

    TABLE 40 NORTH AMERICA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 61

    TABLE 41 NORTH AMERICA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 62

    TABLE 42 US SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 62

    TABLE 43 US SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 62

    TABLE 44 US SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 63

    TABLE 45 US SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 63

    TABLE 46 US SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 63

    TABLE 47 US SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 63

    TABLE 48 CANADA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 64

    TABLE 49 CANADA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 64

    TABLE 50 CANADA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 64

    TABLE 51 CANADA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 64

    TABLE 52 CANADA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 65

    TABLE 53 CANADA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 65

    TABLE 54 SOUTH AMERICA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 66

    TABLE 55 SOUTH AMERICA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 66

    TABLE 56 SOUTH AMERICA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 66

    TABLE 57 SOUTH AMERICA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 66

    TABLE 58 SOUTH AMERICA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 67

    TABLE 59 SOUTH AMERICA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 67

    TABLE 60 EUROPE SPIROMETRY MARKET, BY REGION 2020-2027 (USD MILLION) 68

    TABLE 61 EUROPE SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 69

    TABLE 62 EUROPE SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 69

    TABLE 63 EUROPE SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 69

    TABLE 64 EUROPE SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 69

    TABLE 65 EUROPE SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 70

    TABLE 66 EUROPE SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 70

    TABLE 67 WESTERN EUROPE SPIROMETRY MARKET, BY COUNTRY 2020-2027 (USD MILLION) 71

    TABLE 68 WESTERN EUROPE SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 71

    TABLE 69 WESTERN EUROPE SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 72

    TABLE 70 WESTERN EUROPE SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 72

    TABLE 71 WESTERN EUROPE SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 72

    TABLE 72 WESTERN EUROPE SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 72

    TABLE 73 WESTERN EUROPE SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 73

    TABLE 74 GERMANY SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 73

    TABLE 75 GERMANY SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 73

    TABLE 76 GERMANY SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 74

    TABLE 77 GERMANY SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 74

    TABLE 78 GERMANY SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 74

    TABLE 79 GERMANY SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 74

    TABLE 80 UK SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 75

    TABLE 81 UK SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 75

    TABLE 82 UK SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 75

    TABLE 83 UK SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 75

    TABLE 84 UK SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 76

    TABLE 85 UK SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 76

    TABLE 86 FRANCE SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 77

    TABLE 87 FRANCE SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 77

    TABLE 88 FRANCE SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 77

    TABLE 89 FRANCE SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 77

    TABLE 90 FRANCE SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 78

    TABLE 91 FRANCE SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 78

    TABLE 92 SPAIN SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 79

    TABLE 93 SPAIN SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 79

    TABLE 94 SPAIN SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 79

    TABLE 95 SPAIN SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 79

    TABLE 96 SPAIN SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 80

    TABLE 97 SPAIN SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 80

    TABLE 98 ITALY SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 81

    TABLE 99 ITALY SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 81

    TABLE 100 ITALY SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 81

    TABLE 101 ITALY SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 81

    TABLE 102 ITALY SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 82

    TABLE 103 ITALY SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 82

    TABLE 104 REST OF WESTERN EUROPE SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 83

    TABLE 105 REST OF WESTERN EUROPE SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 83

    TABLE 106 REST OF WESTERN EUROPE SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE

    2020-2027 (USD MILLION) 83

    TABLE 107 REST OF WESTERN EUROPE SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 84

    TABLE 108 REST OF WESTERN EUROPE SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 84

    TABLE 109 REST OF WESTERN EUROPE SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 84

    TABLE 110 EASTERN EUROPE SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 85

    TABLE 111 EASTERN EUROPE SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 85

    TABLE 112 EASTERN EUROPE SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 85

    TABLE 113 EASTERN EUROPE SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 85

    TABLE 114 EASTERN EUROPE SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 86

    TABLE 115 EASTERN EUROPE SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 86

    TABLE 116 ASIA PACFIC SPIROMETRY MARKET, BY COUNTRY 2020-2027 (USD MILLION) 87

    TABLE 117 ASIA-PACIFIC SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 88

    TABLE 118 ASIA-PACIFIC SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 88

    TABLE 119 ASIA-PACIFIC SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 88

    TABLE 120 ASIA-PACIFIC SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 88

    TABLE 121 ASIA-PACIFIC SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 89

    TABLE 122 ASIA-PACIFIC SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 89

    TABLE 123 CHINA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 90

    TABLE 124 CHINA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 90

    TABLE 125 CHINA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 90

    TABLE 126 CHINA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 90

    TABLE 127 CHINA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 91

    TABLE 128 CHINA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 91

    TABLE 129 JAPAN SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 92

    TABLE 130 JAPAN SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 92

    TABLE 131 JAPAN SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 92

    TABLE 132 JAPAN SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 92

    TABLE 133 JAPAN SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 93

    TABLE 134 JAPAN SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 93

    TABLE 135 INDIA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 94

    TABLE 136 INDIA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 94

    TABLE 137 INDIA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 94

    TABLE 138 INDIA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 94

    TABLE 139 INDIA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 95

    TABLE 140 INDIA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 95

    TABLE 141 AUSTRALIA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 96

    TABLE 142 AUSTRALIA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 96

    TABLE 143 AUSTRALIA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 96

    TABLE 144 AUSTRALIA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 96

    TABLE 145 AUSTRALIA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 97

    TABLE 146 AUSTRALIA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 97

    TABLE 147 SOUTH KOREA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 98

    TABLE 148 SOUTH KOREA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 98

    TABLE 149 SOUTH KOREA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 98

    TABLE 150 SOUTH KOREA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 98

    TABLE 151 SOUTH KOREA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 99

    TABLE 152 SOUTH KOREA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 99

    TABLE 153 REST OF ASIA-PACIFIC SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 100

    TABLE 154 REST OF ASIA-PACIFIC SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 100

    TABLE 155 REST OF ASIA-PACIFIC SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 100

    TABLE 156 REST OF ASIA-PACIFIC SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 100

    TABLE 157 REST OF ASIA-PACIFIC SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 101

    TABLE 158 REST OF ASIA-PACIFIC SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 101

    TABLE 159 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY REGION 2020-2027 (USD MILLION) 102

    TABLE 160 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 102

    TABLE 161 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 103

    TABLE 162 MIDDLE EAST & AFRICA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 103

    TABLE 163 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 103

    TABLE 164 MIDDLE EAST & AFRICA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 103

    TABLE 165 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 104

    TABLE 166 MIDDLE EAST SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 104

    TABLE 167 MIDDLE EAST SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 104

    TABLE 168 MIDDLE EAST SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 105

    TABLE 169 MIDDLE EAST SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 105

    TABLE 170 MIDDLE EAST SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 105

    TABLE 171 MIDDLE EAST SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 105

    TABLE 172 AFRICA SPIROMETRY MARKET, BY PRODUCT 2020-2027 (USD MILLION) 106

    TABLE 173 AFRICA SPIROMETRY MARKET, BY TECHNOLOGY 2020-2027 (USD MILLION) 106

    TABLE 174 AFRICA SPIROMETRY MARKET FOR FLOW MEASUREMENT SPIROMETRY, BY TYPE 2020-2027 (USD MILLION) 106

    TABLE 175 AFRICA SPIROMETRY MARKET, BY APPLICATION 2020-2027 (USD MILLION) 106

    TABLE 176 AFRICA SPIROMETRY MARKET FOR DIAGNOSTIC TYPE, BY TYPE 2020-2027 (USD MILLION) 107

    TABLE 177 AFRICA SPIROMETRY MARKET, BY END USER 2020-2027 (USD MILLION) 107

    TABLE 178 GLOBAL SPIROMETRY MARKET: KEY DEVELOPMENT 111


    15 List of Figures

    FIGURE 1 GLOBAL SPIROMETRY MARKET: MARKET STRUCTURE 20

    FIGURE 2 RESEARCH PROCESS OF MRFR 22

    FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 25

    FIGURE 4 PORTER’S FIVE FORCES MODEL 35

    FIGURE 5 SUPPLY CHAIN: GLOBAL SPIROMETRY MARKET 36

    FIGURE 6 GLOBAL SPIROMETRY MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 40

    FIGURE 7 GLOBAL SPIROMETRY MARKET, BY TECHNOLOGY 2020 & 2027 (USD MILLION) 43

    FIGURE 8 GLOBAL SPIROMETRY MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 48

    FIGURE 9 GLOBAL SPIROMETRY MARKET, BY END USER 2020 & 2027 (USD MILLION) 53

    FIGURE 10 GLOBAL SPIROMETRY MARKET, BY REGION 2020 & 2027 (USD MILLION) 56

    FIGURE 11 AMERICAS SPIROMETRY MARKET, BY REGION COUNTRY 2020 (%) 58

    FIGURE 12 NORTH AMERICA SPIROMETRY MARKET, BY COUNTRY 2020 (%) 60

    FIGURE 13 EUROPE SPIROMETRY MARKET, BY REGION 2020 (%) 68

    FIGURE 14 WESTERN EUROPE SPIROMETRY MARKET, BY COUNTRY 2020 (%) 71

    FIGURE 15 ASIA PACFIC SPIROMETRY MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 87

    FIGURE 16 MIDDLE EAST & AFRICA SPIROMETRY MARKET, BY COUNTRY 2020 (%) 102

    FIGURE 17 GLOBAL SPIROMETRY MARKET COMPETITIVE LANDSCAPE (%) 109

    FIGURE 18 GLOBAL SPIROMETRY MARKET, MARKET SHARE ANALYSIS 2020 (%) 110

    Spirometry Market: Competitive Landscape


    NDD Medical Technologies, Inc., CareFusion Corporation, Nihon Kohden Corporation, Smiths Medical, Schiller AG, collectively accounted for more than 70% of the market share of the global spirometry market in 2017. These companies continue to retain their strong global presence through expansion, merger & acquisition, and extensive product portfolio.


    The global spirometry market is currently dominated by NDD Medical Technologies, Inc. with 34.6% of the total market share. NDD Medical Technologies, Inc. is a medical equipment and device provider company. The company’s products include spirometers, complete portable pulmonary function equipment, pc-based spirometry, true flow ultrasound technology, respiratory therapy, and lung health.


    CareFusion Corporation accounted for the second position in the global market share in spirometry market in 2017. The company is a subsidiary of Becton Dickinson, is a global corporation health care industry with product and services that helps improves the cost and safety of health care. The company develops market leading technologies for respiratory product and series ventilation. In March 2015, CareFusion joined Becton Dickinson to form a global leader in medication management and patient’s safety solutions.


    Nihon Kohden Corporation held third position in the global spirometry market. The company develops, produces, and sells medical electronic equipment in Japan and internationally. It provides physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring systems, and polygraphs for cath labs, diagnostic information systems, and related consumables, such as recording paper, electrodes and catheters, and maintenance services.


    Smiths Medical, Inc. develops, manufactures, and supplies medical devices and equipment for hospitals, emergency, home, and specialist environments. It offers emergency healthcare solutions for military and homeland defense. The products are used in adult critical care, alternate care, anesthesia, assisted reproduction, cardiac care, diabetes, medical-surgical, neo and pediatric critical care, oncology, pain management, respiratory care, and sleep medicine. The company offers its products through its sales and distribution network in the US and internationally.


    Schiller is a world-leading manufacturer and supplier of devices for cardiopulmonary diagnostic, defibrillation, and patient monitoring as well as for software solutions for the medical industry. Schiller has launched a handy emergency electro-cardio scope that was ten times lighter than other devices.


    In the spirometry market, numerous companies are involved in the manufacturing of the various types of spirometers. Major companies have a huge brand identity and product portfolio. These companies have adopted the organic strategy of product launches and acquisitions to gain the market. These strategies implied by the players in this market is continuous innovation and development of the new and better products to beat the opponents and strive in this big market.